The PROTEA trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV-1 RNA below 50 copies/mL

The PROTEA trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV-1 RNA below 50 copies/mL

Bibliographic Details
Main Authors: Antinori, Andrea, Arribas, Jose, Fehr, Jan, Girard, Pierre-Marie, Horban, Andrzej, Hill, Andrew, van Delft, Yvon, Moecklinghoff, Christiane
Format: Online
Language:English
Published: International AIDS Society 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224888/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224888/

Similar Items